Aurelie Garant, M.D.
Assistant Professor

Medical School

Université Laval, Canada (2012)

Residency

McGill University Health Centre (2017), Radiation Oncology

Fellowship

Mayo Clinic (2018), Advanced Radiation Oncology

• Bladder cancer in women
• Prostate cancer protocols
• RCC spine metastases
• Rectal cancer in elderly patients

Featured Publications

Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer.

Hannan R, Christensen M, Hammers H, Christie A, Paulman B, Lin D, Garant A, Arafat W, Courtney K, Bowman I, Cole S, Sher D, Ahn C, Choy H, Timmerman R, Brugarolas J, Eur Urol Oncol 2021 Dec

Stereotactic Ablative Radiotherapy for High-Risk Prostate Cancer-a Prospective Multi-level MRI-based Dose Escalation Trial.

Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine A, Kim DWN, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, TimmermanMD RD, Int J Radiat Oncol Biol Phys 2021 Nov

Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy.

McLaughlin MF, Folkert MR, Timmerman RD, Hannan R, Garant A, Hudak SJ, Costa DN, Desai NB, Adv Radiat Oncol 2021 Jul-Aug 6 4 100713

Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC.

All S, Garant A, Hannan R, Semin Radiat Oncol 2021 Jul 31 3 227-234

Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.

Miranda AF, Howard JM, McLaughlin M, Meng X, Clinton T, Sanli Ö, Garant A, Bagrodia A, Margulis V, Lotan Y, Hannan R, Desai N, Woldu SL, Urol Oncol 2021 Jun

A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy.

Balagopal A, Nguyen D, Morgan H, Weng Y, Dohopolski M, Lin MH, Barkousaraie AS, Gonzalez Y, Garant A, Desai N, Hannan R, Jiang S, Med Image Anal 2021 May 72 102101

Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial.

Garant A, Kavan P, Martin AG, Azoulay L, Vendrely V, Lavoie C, Vasilevsky CA, Boutros M, Faria J, Nguyen TN, Ferland E, Des Groseilliers S, Cloutier AS, Diec H, Drolet S, Richard C, Batist G, Vuong T, Radiother Oncol 2021 02 155 237-245

A Multi-institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer.

Garant A, Spears G, Routman D, Whitaker T, Liao Z, Harmsen W, Liu A, Haddock M, Hallemeier C, Lin S, Merrell K, Pract Radiat Oncol 2021 Jan

Dosimetric impact of physician style variations in contouring CTV for post-operative prostate cancer: A deep learning-based simulation study

Balagopal A, Nguyen D, Mashayekhi M, Morgan H, Garant A, Desai N, Hannan R, Lin M.H., Jiang S arXiv 2021

Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation.

Desai NB, Garant A, Hannan R, Folkert MR, Int J Radiat Oncol Biol Phys 2020 11 108 4 914-916

 Featured Books

Surgical Techniques in Rectal Cancer. In Neoadjuvant Radiotherapy

Vuong T, Garant A. (2018). New York, Springer

Current Therapy in Colon and Rectal Surgery. In Cancer of the Rectum: Neoadjuvant Therapy

Vuong T, Garant A, Niazi T (2016). Amsterdam, Elsevier Sciences

• Texas Super Doctors, Rising Star Award
  (2021)
• Texas Super Doctors, Rising Star Award
  (2020)
• NIH Kidney Cancer SPORE Career Enhancement Program Award
  (2019)
• UT Southwestern Leaders Emerging in Academic Departments (LEAD) Course: Class of 2019
  (2019)
• American Brachytherapy Society Prostate LDR/HDR Scholarship
  (2018)
• Reviewer (by invitation), International Journal of Radiation Oncology Biology Physics
  (2018)
• John D. Earle Radiation Oncology Fellowship Fund, Mayo Clinic, Rochester MN
  (2017-2018)
• McGill University Residency Program Award, Scholar
  (2015-2016)